Experimental universal influenza vaccine candidate, H1ssF_3928, in human trials
by Press Release from Outbreak News Today on (#4CDZP)
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine's safety and tolerability as well as its ability to induce an immune response in healthy volunteers. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, developed the experimental vaccine, known as ["]
The post Experimental universal influenza vaccine candidate, H1ssF_3928, in human trials appeared first on Outbreak News Today.